サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：皮膚科治療薬の世界市場規模調査＆予測、適応症別（にきび、乾癬、酒さ、脱毛症、その他）、地域別分析、2022-2029年
市場調査レポート
商品コード
1251550

皮膚科治療薬の世界市場規模調査＆予測、適応症別（にきび、乾癬、酒さ、脱毛症、その他）、地域別分析、2022-2029年

Global Dermatological Drugs Market Size study & Forecast, by Indication (Acne, Psoriasis, Rosacea, Alopecia, Others) and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
皮膚科治療薬の世界市場規模調査＆予測、適応症別（にきび、乾癬、酒さ、脱毛症、その他）、地域別分析、2022-2029年
出版日: 2023年03月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮膚科治療薬の世界市場は、2021年に約170億米ドルと評価され、予測期間2022-2029年には10.8%以上の健全な成長率で成長すると予測されています。

皮膚科治療薬は、さまざまな皮膚疾患の治療に用いられる医療物質であり、その直接的な関心事はスキンケアです。にきび、円形脱毛症、天疱瘡など、さまざまな皮膚疾患が皮膚科治療薬によって治療されます。皮膚科治療薬の焦点は、皮膚疾患の治療と予防にあります。皮膚疾患の調査、皮膚疾患に関する意識の高まり、革新的な製品への需要の増加、治療薬の承認、研究開発への投資の増加、可処分所得の増加などが、市場の成長を促進する要因となっています。

Health, Pharma &MedTechによると、インドでは2021年に約23%の回答者がニキビやフケなどの皮膚疾患に悩まされています。米国皮膚科学会によると、12歳から24歳の成人の約85％が軽度のにきびを経験しています。皮膚疾患の有病率の増加は、皮膚科薬市場の成長をもたらします。さらに、2023年の世界の皮膚治療は約187億1,000万円となり、そのほとんどが米国で発生しています。皮膚疾患の治療の増加は、市場成長を促進する皮膚疾患に対する意識の向上を示しています。その他、革新的な製品への需要の高まり、治療薬の承認、研究開発への投資の増加、可処分所得の増加などが、市場拡大を促す重要な要素となっています。さらに、ヘルスケア支出の増加や製薬業界の開拓は、大きな市場機会を生み出す要因となっています。しかし、代替品の入手が可能であることが、2022-2029年の予測期間を通じて市場の成長を阻害しています。

皮膚科治療薬の世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。欧州は、皮膚疾患の患者数が多いこと、地下水素貯蔵の導入が進んでいること、水素貯蔵設備の開拓に向けた政府投資の増加、ヘルスケア分野への投資の増加、同地域の水素エネルギーへの投資の増加などにより、収益面で市場を独占しています。北米は、技術的進歩、リアルタイムデータ配信、天然ガス導入に関する意識の高まり、政府規制の支持などの要因により、予測期間中最も高いCAGRで成長すると予想されます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界およびセグメント別市場の推定・予測、2019年～2029年
    • 皮膚科治療薬市場、地域別、2019-2029年
    • 皮膚科治療薬市場、適応症別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 皮膚科治療薬の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 皮膚科治療薬の世界市場力学

  • 皮膚科治療薬市場の影響分析（2019-2029年）
    • 市場促進要因
      • 肌荒れを増長させる
      • 皮膚疾患に対する意識の高まり
    • 市場の課題
      • 代替品の有無
    • 市場機会
      • ヘルスケア費用の増加
      • 医薬品産業の発展

第4章 皮膚科治療薬の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの提言と結論
  • 主な投資機会
  • 主要成功戦略

第5章 リスク評価: COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 皮膚科治療薬の世界市場：適応症別

  • マーケットスナップショット
  • 皮膚科治療薬の世界市場：適応症別、業績別- ポテンシャル分析
  • 皮膚科治療薬の世界市場インディケーション別推定・予測2019-2029
  • 皮膚科治療薬市場、サブセグメント分析
    • にきび
    • 乾癬
    • 酒さ
    • 脱毛症
    • その他

第7章 皮膚科治療薬の世界市場：地域別分析

  • 皮膚科治療薬市場：マーケットスナップショット、地域別
  • 北米
    • 米国
      • 適応症別の推定・予測、2019年～2029年
    • カナダ
  • 欧州皮膚科治療薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の皮膚科治療薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの皮膚科治療薬市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Novartis AG
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Amgen Inc
    • AbbVie Inc
    • Johnson & Johnson Private Limited
    • Leo Pharma A/S
    • Eli Lilly and Company
    • GlaxoSmithKline Plc
    • AstraZeneca plc
    • Pfizer Inc
    • Merck KGaA

第9章 調査のプロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Dermatological Drugs Market, report scope
  • TABLE 2. Global Dermatological Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Dermatological Drugs Market estimates & forecasts by Indication 2019-2029 (USD Billion)
  • TABLE 4. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 5. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. U.S. Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 16. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. Canada Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 18. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. UK Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 21. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. Germany Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 24. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. France Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 27. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. Italy Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 30. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Spain Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 33. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. RoE Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 36. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. China Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 39. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. India Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 42. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. Japan Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 45. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. South Korea Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 48. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. Australia Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 51. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. RoAPAC Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. Brazil Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 57. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Mexico Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 60. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. RoLA Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 63. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. Row Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 66. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. List of secondary sources, used in the study of global Dermatological Drugs Market
  • TABLE 69. List of primary sources, used in the study of global Dermatological Drugs Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Dermatological Drugs Market, research methodology
  • FIG 2. Global Dermatological Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Dermatological Drugs Market, key trends 2021
  • FIG 5. Global Dermatological Drugs Market, growth prospects 2022-2029
  • FIG 6. Global Dermatological Drugs Market, porters 5 force model
  • FIG 7. Global Dermatological Drugs Market, pest analysis
  • FIG 8. Global Dermatological Drugs Market, value chain analysis
  • FIG 9. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Dermatological Drugs Market, regional snapshot 2019 & 2029
  • FIG 15. North America Dermatological Drugs Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Dermatological Drugs Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Dermatological Drugs Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Dermatological Drugs Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Dermatological Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Dermatological Drugs Market is valued at approximately USD 17.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2022-2029. Dermatological drugs are medical substances used to treat a variety of skin disorders and their direct concern is skin care. Various skin disorders such as Acne, Alopecia Areata, Pemphigus, and more are treated through dermatological drugs. The focus of Dermatological drugs is to cure and prevent skin disorders. Increasing skin conditions, growing awareness regarding skin diseases, increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income are the factors driving the growth of the market.

According to Health, Pharma & MedTech, in India, around 23% of the respondents suffered from skin conditions such as acne and dandruff in 2021. According to the American Academy of Dermatology Association, around 85% of adult people aged between 12 to 24 experience minor acne. The increasing prevalence of skin conditions results in the growth of the dermatological drugs market. Additionally, the global skin treatment in 2023 was valued at around 18.71 billion, most of which is generated in the US. Increasing treatment of skin conditions shows the increasing awareness of skin diseases which drives the market growth. Other important components driving market increase are increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income. Furthermore, an increase in healthcare expenditure and the Development of the pharmaceutical industry are the factors creating major market opportunities. However, the availability of alternatives stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Dermatological Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe dominated the market in terms of revenue, owing to the high number of patients with skin diseases, increasing underground hydrogen storage adoption, increasing government investment in the development of hydrogen storage capacities, rising investments in the healthcare sector, and the region's increasing investment in hydrogen energy. North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as technological advancements, real-time data delivery, Increasing awareness regarding the adoption of natural gas and, supportive government regulations

Major market players included in this report are:

  • Novartis AG
  • Amgen Inc
  • AbbVie Inc
  • Johnson & Johnson Private Limited
  • Leo Pharma A/S
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • AstraZeneca plc
  • Pfizer Inc
  • Merck KGaA

Recent Developments in the Market:

  • In July 2021, TWYNEO cream of Sol-Gel Technologies Ltd was approved by US FDA for the treatment of acne vulgaris.
  • In June 2021, Kyowa Kirin Co., Ltd. and Amgen have agreed to work together to develop and market KHK4083 for the treatment of skin diseases such as atopic dermatitis.

Global Dermatological Drugs Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Indication, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Indication offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Indication:

  • Acne
  • Psoriasis
  • Rosacea
  • Alopecia
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Dermatological Drugs Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Dermatological Drugs Market, by Indication, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Dermatological Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Dermatological Drugs Market Dynamics

  • 3.1. Dermatological Drugs Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing skin conditions
      • 3.1.1.2. Growing awareness regarding skin diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. Availability of alternatives
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in healthcare expenditure
      • 3.1.3.2. Development of the pharmaceutical industry

Chapter 4. Global Dermatological Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Dermatological Drugs Market, by Indication

  • 6.1. Market Snapshot
  • 6.2. Global Dermatological Drugs Market by Indication, Performance - Potential Analysis
  • 6.3. Global Dermatological Drugs Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
  • 6.4. Dermatological Drugs Market, Sub Segment Analysis
    • 6.4.1. Acne
    • 6.4.2. Psoriasis
    • 6.4.3. Rosacea
    • 6.4.4. Alopecia
    • 6.4.5. Others

Chapter 7. Global Dermatological Drugs Market, Regional Analysis

  • 7.1. Dermatological Drugs Market, Regional Market Snapshot
  • 7.2. North America Dermatological Drugs Market
    • 7.2.1. U.S. Dermatological Drugs Market
      • 7.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
    • 7.2.2. Canada Dermatological Drugs Market
  • 7.3. Europe Dermatological Drugs Market Snapshot
    • 7.3.1. U.K. Dermatological Drugs Market
    • 7.3.2. Germany Dermatological Drugs Market
    • 7.3.3. France Dermatological Drugs Market
    • 7.3.4. Spain Dermatological Drugs Market
    • 7.3.5. Italy Dermatological Drugs Market
    • 7.3.6. Rest of Europe Dermatological Drugs Market
  • 7.4. Asia-Pacific Dermatological Drugs Market Snapshot
    • 7.4.1. China Dermatological Drugs Market
    • 7.4.2. India Dermatological Drugs Market
    • 7.4.3. Japan Dermatological Drugs Market
    • 7.4.4. Australia Dermatological Drugs Market
    • 7.4.5. South Korea Dermatological Drugs Market
    • 7.4.6. Rest of Asia Pacific Dermatological Drugs Market
  • 7.5. Latin America Dermatological Drugs Market Snapshot
    • 7.5.1. Brazil Dermatological Drugs Market
    • 7.5.2. Mexico Dermatological Drugs Market
  • 7.6. Rest of The World Dermatological Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Novartis AG
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Amgen Inc
    • 8.2.3. AbbVie Inc
    • 8.2.4. Johnson & Johnson Private Limited
    • 8.2.5. Leo Pharma A/S
    • 8.2.6. Eli Lilly and Company
    • 8.2.7. GlaxoSmithKline Plc
    • 8.2.8. AstraZeneca plc
    • 8.2.9. Pfizer Inc
    • 8.2.10. Merck KGaA

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption